Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 03 2021
Historique:
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 20 5 2021
Statut: epublish

Résumé

Motor neuron disease (MND) is a rapidly progressive and fatal neurodegenerative disorder with limited treatment options. The Motor Neuron Disease Systematic Multi-Arm Randomised Adaptive Trial (MND-SMART) is a multisite UK trial seeking to address the paucity in effective disease-modifying drugs for people with MND (pwMND). Historically, neurological trials have been plagued by suboptimal recruitment and high rates of attrition. Failure to recruit and/or retain participants can cause insufficiently representative samples, terminated trials or invalid conclusions. This study investigates patient-specific factors affecting recruitment and retention of pwMND to MND-SMART. Improved understanding of these factors may improve trial protocol design, optimise recruitment and retention. PwMND on the Scottish MND Register, Clinical Audit Research and Evaluation of MND (CARE-MND), will be invited to participate in a prospective observational cohort study that investigates factors affecting trial participation and attrition. We hypothesise that patient-specific factors will significantly affect trial recruitment and retention. Participants will complete the Hospital Anxiety and Depression Scale, 9-Item Patient Health Questionnaire and State-Trait Anxiety Inventory-Form Y to evaluate neuropsychiatric symptoms, the ALS-Specific Quality of Life Questionnaire-Brief Form and Centre for Disease Control and Prevention-Health-Related Quality of Life for quality of life and a novel study-specific questionnaire on Attitudes towards Clinical Trial Participation (ACT-Q). Clinical data on phenotype, cognition (Edinburgh Cognitive and Behavioural ALS Screen) and physical functioning (Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised) will also be collated. Caregivers will complete the Brief Dimensional Apathy Scale. After 12 months, a data request to MND-SMART will evaluate recruitment and retention. Descriptive statistics will summarise and compare assessments and participants reaching impairment thresholds. Variable groupings: attitudes, quality of life, cognition, behaviour, physical functioning, neuropsychiatric and phenotype. Univariate and multivariable logistic regression will explore association with participation/withdrawal in MND-SMART; presented as ORs and 95% CIs. Ethical approval was provided by the West of Scotland Research Ethics Committee 3 (20/WS/0067) on 12 May 2020. The results of this study will be published in a peer-reviewed journal, presented at academic conferences and disseminated to participants and the public.

Identifiants

pubmed: 33757953
pii: bmjopen-2020-044996
doi: 10.1136/bmjopen-2020-044996
pmc: PMC7993162
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e044996

Subventions

Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Professor Carson is a paid editor at Journal of Neurology, Neurosurgery and Psychiatry, and gives independent testimony in Court on a range of neuropsychiatric topics.

Références

Muscle Nerve. 2018 Nov;58(5):646-654
pubmed: 30028537
J Clin Nurs. 2010 Jan;19(1-2):227-33
pubmed: 20500260
Trials. 2009 Jun 11;10:39
pubmed: 19519885
Amyotroph Lateral Scler. 2008 Oct;9(5):257-65
pubmed: 18608092
Clin Transl Radiat Oncol. 2018 Oct 04;13:44-49
pubmed: 30345398
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):397-405
pubmed: 23421600
J Intern Med. 2002 Feb;251(2):156-68
pubmed: 11905591
BMJ. 2006 Apr 22;332(7547):969-71
pubmed: 16627519
J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):536-41
pubmed: 1640227
Res Nurs Health. 2001 Dec;24(6):530-9
pubmed: 11746081
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):9-14
pubmed: 23781974
Eur Child Adolesc Psychiatry. 2002 Dec;11(6):266-72
pubmed: 12541005
Neurology. 2019 Apr 2;92(14):e1610-e1623
pubmed: 30850440
BMC Cardiovasc Disord. 2018 Nov 27;18(1):215
pubmed: 30482176
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(7-8):509-518
pubmed: 32573277
Public Health Rep. 1994 Sep-Oct;109(5):665-72
pubmed: 7938388
J Korean Med Sci. 2012 Feb;27(2):200-6
pubmed: 22323869
Ann Oncol. 2000 Aug;11(8):939-45
pubmed: 11038029
J Neurol. 2019 Apr;266(4):817-825
pubmed: 30805795
Postgrad Med. 2012 Sep;124(5):69-77
pubmed: 23095427
Control Clin Trials. 1987 Dec;8(4 Suppl):6S-30S
pubmed: 3326716
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
Eur J Neurol. 2007 Sep;14(9):993-1001
pubmed: 17718691
Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):242-250
pubmed: 30889975
Neurology. 2013 Oct 8;81(15):1350-5
pubmed: 24005339
Health Qual Life Outcomes. 2011 Sep 29;9:82
pubmed: 21955749
Neurology. 2019 Jan 9;:
pubmed: 30626653
Cancer Nurs. 2003 Oct;26(5):376-84; quiz 385-6
pubmed: 14710799
Arch Neurol. 1996 Feb;53(2):141-7
pubmed: 8639063
Clin Neuropsychol. 2020 Feb;34(2):423-435
pubmed: 31154933
Br J Clin Psychol. 2001 Nov;40(4):429-34
pubmed: 11760618
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):663-9
pubmed: 26203157

Auteurs

Emily Beswick (E)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Stella A Glasmacher (SA)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Rachel Dakin (R)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Judith Newton (J)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Alan Carson (A)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Sharon Abrahams (S)

Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Human Cognitive Neurosciences, The University of Edinburgh, Edinburgh, UK.

Siddharthan Chandran (S)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
UK Dementia Research Institute, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.

Suvankar Pal (S)

Centre for Clinical Brain Sciences, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK suvankar.pal@ed.ac.uk.
Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK.
The National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Western General Hospital, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH